logo-loader
viewIntegumen

Integumen's Gerry Brandon details new £3mln facility for Labskin and Covid-19 expansion

Integumen's (LON:SKIN) Gerry Brandon speaks to Proactive London's Andrew Scott after announcing they've secured a new £3mln three-year loan facility that requires no loan repayments until next year. He says the initial drawdown of £1.5mln provides them with sufficient working capital for its COVID-19 AI product development as well as for the expansion of Labskin support services into the US and Asia.

Quick facts: Integumen

Price: 2.69 GBX

AIM:SKIN
Market: AIM
Market Cap: £29.02 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 slides as US/China tensions escalate

Headlines from the Proactive UK newsroom. The FTSE 100 slumped as China shut a US consulate in Chengdu in retaliation to a similar measure in Houston. The blue chip index fell 110 to 6,101. UK retail sales bounced 13.9% month-on-month June, following on from May’s 12.9% increase. Sales...

3 weeks, 1 day ago

2 min read